One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

It’s always a good sign when a couple of big deals are announced right before the conference, and this year we saw a doozie ...

We recently published an article titled Jim Cramer Discussed 9 Stocks for This Week’s Game Plan. In this article, we are ...

After revenue boomed for biopharma manufacturers during the COVID pandemic, sales have stagnated for several CDMO giants, ...

International Growth Composite Portfolio declined by -7.08% gross of fees and -7.36% net of fees, outperforming MSCI All ...